Clinical Trial

A Study of XW003 Injection in Chinese Adolescents With Obesity

Completed Phase 1
View on ClinicalTrials.gov →
Summary
The aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XW003 injection in Chinese adolescents with obesity
Protocol Amendment History 4 changes
critical Trial completed 2026-05-21
notable Primary completion moved earlier: 2026-06-30 -> 2026-04-18 2026-05-21
minor Completion moved earlier: 2026-12-31 -> 2026-04-18 2026-05-21
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-04-14
Trial Details
NCT Number NCT07143227
Lead Sponsor Hangzhou Sciwind Biosciences Co., Ltd.
Conditions Obese Adolescents, Obesity
Enrollment 48 participants
Start Date 2025-08-25
Primary Completion 2026-04-18 (estimated)
Study Completion 2026-04-18 (estimated)
Updated on ClinicalTrials.gov 2026-05-20